SUN PHARMA (SMPQY) share price has Zoomed 6% and is presently trading at Rs 494. Meanwhile, the BSE HEALTHCARE Index is at 13,269 (Up 1.7%).
Among the top Gainers in the BSE HEALTHCARE Index today is SUN PHARMA (up 5.57%).
ERIS LIFESCIENCES LIMITED (down 0.03%) and FORTIS HEALTHCARE (down 0.10%) are among the top losers today.
Over the last one year, SUN PHARMA has moved down from Rs 592 to Rs 494, registering a loss of Rs 97 (down 16.77%)
On the other hand, the BSE HEALTHCARE has moved down from 13,695 to 13,269, loss of 426 points (down 3.14%) during the last 12 months.
The top gainers among the BSE HEALTHCARE Index stocks during this same period were BIOCON LTD (up 111.99%), DIVIS LABORATORIES (up 105.47%) and ABBOTT INDIA (up 61.79%).
What About the Benchmark Indices?
The BSE Sensex is at 35,101 (up 0.49%).
The top gainers among the BSE Sensex stocks today are SUN PHARMA (up 5.57%), GAIL (up 2.03%) and BHEL (up 1.73%). Other gainers include SBI (up 1.50%) and TATA STEEL (up 1.15%). The most traded stocks in the BSE Sensex are SUN PHARMA and SBI.
In the meantime, NSE Nifty is at 10,673 (up 0.58%). SUN PHARMA (up 6.55%) is among the top gainers in NSE Nifty.
Over the last 12 months, the BSE Sensex has moved up from 30,750 to 35,101, registering a gain of 4,351 points (up 14.13%).
SUN PHARMA Financial Update...
SUN PHARMA net profit grew 23.1% YoY to Rs 4 billion for the quarter ended December 2017, compared to a profit of Rs 17 billion a year ago. Net Sales rose 84.1% to Rs 66.5 billion during the period as against Rs 79.1 billion in October-December 2016.
For the year ended March 2017, SUN PHARMA reported 123.6% increase in net profit to Rs 78.4 billion compared to net profit of Rs 63.4 billion during FY16.
Revenue of the company grew 110.9% to Rs 316 billion during FY17.
The current Price to earnings ratio of SUN PHARMA, based on rolling 12 month earnings, stands at 42.3x.
Comments
Log in or sign up to join the conversation.